Exploring Epigenomic Processes and Non Coding RNAs in HIV AIDS R21 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

Exploring Epigenomic Processes and Non-Coding RNAs in HIV/AIDS (R21)

The summary for the Exploring Epigenomic Processes and Non-Coding RNAs in HIV/AIDS (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	EXPLORING EPIGENOMIC PROCESSES AND NON-CODING RNAS IN HIV/AIDS (R21)
Federal Agency Name:	National Institutes of Health
Program Name:	Drug Abuse and Addiction Research Programs
Grant Categories:	Education Health
CFDA Number:	93.279
Funding Opportunity Number:	RFA-DA-10-011
Posted Date:	Sep 03, 2009
Creation Date:	Sep 03, 2009
Original Application Deadline:	Dec 23, 2009
Current Application Deadline:	Dec 23, 2009
Archive Date:	Jan 23, 2010
Total Program Funding:	$2,500,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose. The purpose of this FOA issued by the National Institute of Drug Abuse, National Institutes of Health, is to enhance our understanding of the role of epigenomics in HIV infection and pathogenesis in combination with substance abuse. This FOA invites applications proposing innovative research to stimulate new areas of research or develop new approaches to existing studies. Newly-formed collaborations to foster sharing of expertise between the fields of HIV/AIDS, drug abuse, and epigenomics research are encouraged. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, RFA-DA-10-010, that solicits applications under the Research Project Grant (R01) mechanism. Funds Available and Anticipated Number of Awards. A total of $2.5 million has been set aside for this R21 FOA (RFA-DA-10-011) and the companion R01 FOA (RFA-DA-10-010). It is anticipated that 2-4 R01s and 4-6 R21s could be funded.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-da-10-011.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • NIDA Research Center of Excellence Grant Program (P50); • Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R21); • Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R01); • Medications Development Centers of Excellence Cooperative Program (U54); • Drug Abuse Dissertation Research (R36); • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...; • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...; • Pediatric Critical Care and Trauma Scientist Development Program (K12); • Evidence-based Demonstration Projects in Immunization (Admin Supp); • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...